Integer Holdings Pre-Tax Profit Margin 2010-2022 | ITGR

Integer Holdings pre-tax profit margin from 2010 to 2022. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
Integer Holdings Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
2022-03-31 $1.24B $0.09B 7.25%
2021-12-31 $1.22B $0.10B 8.27%
2021-09-30 $1.18B $0.10B 8.24%
2021-06-30 $1.11B $0.11B 9.49%
2021-03-31 $1.04B $0.07B 7.15%
2020-12-31 $1.07B $0.09B 8.01%
2020-09-30 $1.13B $0.08B 6.90%
2020-06-30 $1.20B $0.08B 6.84%
2020-03-31 $1.27B $0.12B 9.20%
2019-12-31 $1.26B $0.11B 8.34%
2019-09-30 $1.24B $0.12B 9.71%
2019-06-30 $1.24B $0.07B 5.74%
2019-03-31 $1.24B $0.07B 5.50%
2018-12-31 $1.21B $0.06B 5.02%
2018-09-30 $1.14B $0.06B 5.29%
2018-06-30 $1.12B $0.09B 8.33%
2018-03-31 $1.08B $0.07B 6.56%
2017-12-31 $1.14B $0.05B 4.31%
2017-09-30 $0.96B $0.06B 5.94%
2017-06-30 $1.02B $0.05B 4.60%
2017-03-31 $1.09B $0.04B 3.49%
2016-12-31 $1.08B $0.03B 2.70%
2016-09-30 $1.35B $-0.04B -2.97%
2016-06-30 $1.15B $-0.05B -4.28%
2016-03-31 $0.97B $-0.04B -3.91%
2015-12-31 $0.80B $-0.02B -1.87%
2015-09-30 $0.65B $0.04B 5.97%
2015-06-30 $0.68B $0.06B 8.55%
2015-03-31 $0.68B $0.06B 9.48%
2014-12-31 $0.69B $0.08B 11.05%
2014-09-30 $0.70B $0.07B 10.07%
2014-06-30 $0.69B $0.07B 9.70%
2014-03-31 $0.69B $0.06B 9.28%
2013-12-31 $0.66B $0.05B 7.38%
2013-09-30 $0.65B $0.03B 5.26%
2013-06-30 $0.64B $0.02B 2.50%
2013-03-31 $0.64B $0.01B 1.26%
2012-12-31 $0.65B $0.01B 1.08%
2012-09-30 $0.63B $0.02B 3.18%
2012-06-30 $0.60B $0.03B 5.17%
2012-03-31 $0.58B $0.04B 6.38%
2011-12-31 $0.57B $0.05B 8.60%
2011-09-30 $0.56B $0.06B 10.87%
2011-06-30 $0.56B $0.06B 10.79%
2011-03-31 $0.55B $0.06B 10.73%
2010-12-31 $0.53B $0.05B 9.38%
2010-09-30 $0.53B $0.02B 4.18%
2010-06-30 $0.52B $-0.02B -2.88%
2010-03-31 $0.51B $-0.02B -3.70%
2009-12-31 $0.52B $-0.02B -3.45%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $2.397B $1.221B
Integer Holdings Corporation manufactures and develops medical devices and components primarily for original equipment manufacturers, which depend on it to design, develop and produce intellectual property protected medical device technologies. Integer Holdings operates through two segments: Medical Sales and Non-Medical Sales. Medical Sales has three sub-segments Advanced Surgical, Orthopedics and Portable Medical; Cardio and Vascular; and Cardiac Rhythm Management & Neuromodulation.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $213.272B 21.66
Edwards Lifesciences (EW) United States $60.297B 42.35
Alcon (ALC) Switzerland $34.105B 29.74
STERIS (STE) Ireland $20.806B 26.28
Fresenius Medical Care AG KGaA (FMS) Germany $14.622B 13.13
Teleflex (TFX) United States $12.103B 19.34
Globus Medical (GMED) United States $5.886B 29.36
Penumbra (PEN) United States $4.964B 313.69
Glaukos (GKOS) United States $2.237B 0.00
Nevro (NVRO) United States $1.735B 0.00
Paragon 28 (FNA) United States $1.271B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.258B 22.52
Artivion (AORT) United States $0.780B 84.30